Allergy Therapeutics PLC Stock
Your prediction
Allergy Therapeutics PLC Stock
Heavy losses for Allergy Therapeutics PLC today as the stock fell by -€0.007 (-10.660%).
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | -10.660% | -19.259% | -24.828% | -38.764% | -53.419% | 172.500% | -81.336% |
| Eledon Pharmaceuticals Inc. | -1.300% | -7.879% | -1.935% | -7.879% | 137.500% | 159.829% | -43.178% |
| Beximco Pharmaceuticals Ltd. GDR | 0.970% | -24.638% | -13.333% | 22.642% | 16.071% | 35.417% | -40.230% |
| SELLAS Life Sciences Group Inc | -2.260% | -21.938% | -18.341% | 479.085% | 212.522% | 491.455% | 19.488% |
News
D-Wave Quantum Just Announced an Expanded Deal. Should You Buy the Stock Now?
Shares of D-Wave Quantum (NYSE: QBTS) jumped Monday morning on the announcement that AT&T (NYSE: T) is expanding its use of the company's quantum computing technology across its network operations
Why D-Wave Quantum Stock Surged Today
Shares of D-Wave Quantum (NASDAQ: QBTS) soared on Monday after the advanced computing pioneer broadened its partnership with AT&T (NYSE: T).
Image source: Getty Images.
Early tests of D-Wave's quan
Stock Market Today, July 27: D-Wave Surges on Nasdaq Debut and Expanded AT&T Deal
D-Wave Quantum (NASDAQ:QBTS), a quantum computing systems and services provider, closed at $19.51, up 20.36%. An expanded agreement with AT&T (NYSE:T) and the stock’s Nasdaq listing debut drove the